Wells Fargo’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.34K | Sell |
628
-36,350
| -98% | -$77.8K | ﹤0.01% | 5812 |
|
|
2025
Q1 | $42.5K | Sell |
36,978
-4,192
| -10% | -$4.82K | ﹤0.01% | 5003 |
|
|
2024
Q4 | $90.2K | Buy |
41,170
+7,768
| +23% | +$17K | ﹤0.01% | 4764 |
|
|
2024
Q3 | $72.8K | Buy |
33,402
+5,363
| +19% | +$11.7K | ﹤0.01% | 4792 |
|
|
2024
Q2 | $64.8K | Buy |
28,039
+13,038
| +87% | +$30.1K | ﹤0.01% | 4819 |
|
|
2024
Q1 | $82.5K | Buy |
15,001
+2,772
| +23% | +$15.2K | ﹤0.01% | 4632 |
|
|
2023
Q4 | $30.2K | Sell |
12,229
-18,256
| -60% | -$45.1K | ﹤0.01% | 5043 |
|
|
2023
Q3 | $1.06M | Sell |
30,485
-6,643
| -18% | -$231K | ﹤0.01% | 3048 |
|
|
2023
Q2 | $1.22M | Buy |
37,128
+22,398
| +152% | +$735K | ﹤0.01% | 3145 |
|
|
2023
Q1 | $493K | Buy |
14,730
+12,715
| +631% | +$426K | ﹤0.01% | 3621 |
|
|
2022
Q4 | $66.1K | Sell |
2,015
-2,179
| -52% | -$71.5K | ﹤0.01% | 4439 |
|
|
2022
Q3 | $146K | Sell |
4,194
-139
| -3% | -$4.84K | ﹤0.01% | 4129 |
|
|
2022
Q2 | $53K | Buy |
4,333
+1,964
| +83% | +$24K | ﹤0.01% | 4728 |
|
|
2022
Q1 | $32K | Sell |
2,369
-3,737
| -61% | -$50.5K | ﹤0.01% | 5511 |
|
|
2021
Q4 | $121K | Buy |
+6,106
| New | +$121K | ﹤0.01% | 5141 |
|